Oral Excipients

Wilmington, DE and Harleysville, PA | October 1, 2026 SPI Pharma, a global leader in pharmaceutical excipients, antacid actives, and...

Abstract Background/Objectives: Scabies is a disease that disproportionately affects young children. Oral ivermectin is a mainstay of scabies therapy, yet...

Abstract Oral bioavailability (%F) is a key determinant of drug efficacy and a critical decision-making parameter in early-stage drug development....

The promise of oral biologics continues to drive innovation across the pharmaceutical industry.  While permeation enhancement remains critical for successful...

Abstract Porous silicates have been investigated as drug carriers to promote the solubility and in vitro dissolution of poorly water-soluble...

Learn from the Capsugel experts at CPHI Worldwide 2026 The experts from Capsugel have taken the stage to share forward-looking...

Abstract Diabetes mellitus currently affects an estimated 635 million individuals worldwide. Insulin therapy remains the primary treatment option for patients...

Abstract Oral metformin is the most prescribed therapy for type 2 diabetes mellitus, nevertheless, the bioavailability remains low and variable....

Abstract Hesperetin (HSP), a naturally occurring citrus flavanone with diverse antioxidant, anti-inflammatory, and pharmacological activities, has attracted considerable attention as...

Abstract Sorafenib is an orally administered multikinase inhibitor whose clinical utility is limited by extremely low aqueous solubility and poor...